Noval, Elora Thanna B.

HRN: 26-20-74  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/14/2024
CEFUROXIME 750MG (VIAL)
11/14/2024
11/15/2024
IV
750
Q8
SP LTCS
Rejected 

 Indication:  Prophylaxis    Type of Infection:  Intra-abdominal    Compliance to guidelines: Non-compliant To Guidelines